Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
Titel:
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
Auteur:
Degasperi, E. De Silvestri, A. Anolli, M.P. Sambarino, D. Borghi, M. Perbellini, R. Facchetti, F. Soffredini, R. Monico, S. De Ledinghen, V. Metivier, S. Jachs, M. Reiberger, T. D'Offizi, G. Dietz-Fricke, C. Papatheodoridis, G. Brunetto, M.R. Verucchi, G. Ciancio, A. Zoulim, F. Mangia, A. Hilleret, M.N. Santantonio, T. A Coppola, N. Pellicelli, A. Roche, B. Causse, X. D'Alteroche, L. Dumortier, J. Ganne, N. Heluwaert, F. Ollivier, I. Loglio, A. ViganĂ², M. Federico, A. Pileri, F. Maracci, M. Tonnini, M. Arpurt, J.P. Barange, K. Billaud, E. Pol, S. Gervais, A. Minello, A. Rosa, I. Puoti, M. Lampertico, P.